NYSE:OMI - Owens & Minor Stock Price, News & Analysis

Owens & Minor trades on the New York Stock Exchange (NYSE) under the ticker symbol "OMI."

Owens & Minor announced a quarterly dividend on Wednesday, August 7th. Stockholders of record on Monday, September 16th will be paid a dividend of $0.002 per share on Monday, September 30th. This represents a $0.01 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date is Friday, September 13th. View Owens & Minor's Dividend History.

Owens & Minor, Inc. (NYSE:OMI) announced its quarterly earnings data on Wednesday, August, 7th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.03. The business had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. Owens & Minor had a negative net margin of 2.88% and a positive return on equity of 5.53%. Owens & Minor's revenue was up 1.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.32 EPS. View Owens & Minor's Earnings History.

Owens & Minor is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for Owens & Minor.

Owens & Minor issued an update on its FY 2019 earnings guidance on Wednesday, August, 7th. The company provided EPS guidance of $0.60-0.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.61.

5 brokers have issued 1 year price objectives for Owens & Minor's shares. Their forecasts range from $5.00 to $9.00. On average, they expect Owens & Minor's stock price to reach $7.30 in the next year. This suggests a possible upside of 25.2% from the stock's current price. View Analyst Price Targets for Owens & Minor.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Owens & Minor in the last year. There are currently 1 sell rating and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Owens & Minor.

Headlines about OMI stock have been trending negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Owens & Minor earned a news sentiment score of -2.9 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Owens & Minor.

Some companies that are related to Owens & Minor include Corcept Therapeutics (CORT), Inspire Medical Systems (INSP), Madrigal Pharmaceuticals (MDGL), Ironwood Pharmaceuticals (IRWD), Supernus Pharmaceuticals (SUPN), Brookdale Senior Living (BKD), BioTelemetry (BEAT), Atrion (ATRI), Regenxbio (RGNX), Hexo (HEXO), Rhoen Klinikum (RHK), Audentes Therapeutics (BOLD), G1 Therapeutics (GTHX), Polynovo (PNV) and Coherus Biosciences (CHRS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Owens & Minor investors own include AT&T (T), Micron Technology (MU), AbbVie (ABBV), Alibaba Group (BABA), Omega Healthcare Investors (OHI), Applied Materials (AMAT), Cisco Systems (CSCO), Tanger Factory Outlet Centers (SKT), 3M (MMM) and Simon Property Group (SPG).

Owens & Minor's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.86%), Vanguard Group Inc. (7.55%), JPMorgan Chase & Co. (4.55%), Blackstone Group Inc (4.11%), Invesco Ltd. (3.82%) and Morgan Stanley (2.86%). Company insiders that own Owens & Minor stock include Charles C Colpo and Geoff Taylor Marlatt. View Institutional Ownership Trends for Owens & Minor.

OMI stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Parametric Portfolio Associates LLC, SG Americas Securities LLC, LSV Asset Management, Wells Fargo & Company MN, GSA Capital Partners LLP, Cubist Systematic Strategies LLC and Aperio Group LLC. View Insider Buying and Selling for Owens & Minor.

OMI stock was acquired by a variety of institutional investors in the last quarter, including Blackstone Group Inc, Invesco Ltd., Renaissance Technologies LLC, Morgan Stanley, BlackRock Inc., Marshall Wace North America L.P., Bank of New York Mellon Corp and Commonwealth Bank of Australia. View Insider Buying and Selling for Owens & Minor.

Shares of OMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OMI stock can currently be purchased for approximately $5.83.

Owens & Minor has a market capitalization of $367.05 million and generates $9.84 billion in revenue each year. The company earns $-437,010,000.00 in net income (profit) each year or $1.15 on an earnings per share basis. Owens & Minor employs 17,900 workers across the globe.View Additional Information About Owens & Minor.

The official website for Owens & Minor is http://www.owens-minor.com/.

Owens & Minor's mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. The company can be reached via phone at 804-723-7000 or via email at [email protected]